How a secretive Pentagon agency seeded the ground for a rapid coronavirus cure - The Washington Post
By 2019, a project DARPA funded at the Massachusetts-based company Moderna demonstrated in a Phase 1 clinical trial that RNA could indeed deliver an antibody to humans and provide protection against the mosquito-borne virus chikungunya. It was an affirmation of Wattendorf’s bet that came after years of DARPA funding the effort.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment